Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
11 2019
Historique:
received: 03 04 2019
revised: 04 07 2019
accepted: 24 07 2019
pubmed: 3 8 2019
medline: 2 10 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

To compare medroxyprogesterone acetate (MPA) concentrations between HIV-positive women on antiretroviral therapy (ART) and HIV-negative women initiating depot medroxyprogesterone (DMPA) injectable. Secondary analysis of 28 HIV-positive women on non-nucleoside reverse transcriptase inhibitor-containing ART regimens and 10 HIV-negative women randomized to initiate DMPA in a clinical trial of progestin contraception in Malawi. MPA concentrations were significantly lower among HIV-positive women on ART, compared with HIV-negative women, at week 4 and week 13 (p=.03 for both), but not at day 3 or week 26 post-DMPA initiation. Antiretroviral medications may affect MPA metabolism in HIV-positive African women.

Identifiants

pubmed: 31374188
pii: S0010-7824(19)30372-5
doi: 10.1016/j.contraception.2019.07.144
pmc: PMC7245365
mid: NIHMS1586152
pii:
doi:

Substances chimiques

Anti-HIV Agents 0
Contraceptive Agents, Female 0
Delayed-Action Preparations 0
Progestins 0
Medroxyprogesterone Acetate C2QI4IOI2G

Banques de données

ClinicalTrials.gov
['NCT02103660']

Types de publication

Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

402-405

Subventions

Organisme : FIC NIH HHS
ID : K01 TW009657
Pays : United States
Organisme : OSELS CDC HHS
ID : U36 OE000002
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Contraception. 2016 Jul;94(1):40-7
pubmed: 26972780
J Reprod Med. 1996 May;41(5 Suppl):381-90
pubmed: 8725700
Pharmacogenomics. 2011 Dec;12(12):1663-70
pubmed: 22118051
J Clin Endocrinol Metab. 1977 Jan;44(1):32-8
pubmed: 833262
Lancet HIV. 2015 Nov;2(11):e474-82
pubmed: 26520927
Contemp Clin Trials. 2017 Jan;52:27-34
pubmed: 27836505
AIDS. 2017 Apr 24;31(7):917-952
pubmed: 28060009
Hum Genomics. 2011 May;5(4):265-82
pubmed: 21712189

Auteurs

Yasaman Zia (Y)

Centers for Disease Control and Prevention, Division of Reproductive Health, Atlanta, GA; Association of Schools and Programs of Public Health, Washington, DC. Electronic address: yaszia@gmail.com.

Jennifer H Tang (JH)

University of North Carolina- Chapel Hill, School of Medicine, Chapel Hill, NC; UNC Project-Malawi, Lilongwe, Malawi.

Lameck Chinula (L)

UNC Project-Malawi, Lilongwe, Malawi.

Gerald Tegha (G)

UNC Project-Malawi, Lilongwe, Malawi.

Frank Z Stanczyk (FZ)

University of Southern California, Los Angeles, CA.

Athena P Kourtis (AP)

Centers for Disease Control and Prevention, Division of Reproductive Health, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH